• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 416608 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1416994275 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1416994275 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Traders Get Bullish on Shares of Chelsea Therapeutics International, Shares Up 5.9% (CHTP)

Published on Mon, 01/07/2013 - 13:23
By Adrienne Chilton

Chelsea Therapeutics International (NASDAQ:CHTP) is one of today's best performing penny stocks, up 5.9% to $0.90 on 1.0x average daily volume. Thus far today, Chelsea Therapeutics International has traded 1.5 million shares, vs. average volume of 1.5 million shares per day. The stock has outperformed the Dow (5.9% to the Dow's -0.6%) and outperformed the S&P 500 (5.9% to the S&P's -0.6%) during today's trading.

In the past 52 weeks, shares of Chelsea Therapeutics International have traded between a low of $0.70 and a high of $5.23 and are now at $0.90, which is 28% above that low price. Over the past week, the 200-day moving average (MA) has gone down 3.5% while the 50-day MA has declined 3.1%.

Chelsea Therapeutics International Ltd. is a biopharmaceutical company developing a pipeline of low toxicity antifolate compounds engineered to have anti-inflammatory and anti-tumor activity. The Company's lead candidate is in development as a metabolically inert treatment alternative to Methotrexate for rheumatoid arthritis, psoriasis, and other disorders.

Potential upside of 291.1% exists for Chelsea Therapeutics International, based on a current level of $0.90 and analysts' average consensus price target of $3.50. The stock should run into initial resistance at its 50-day moving average (MA) of $1.29 and subsequent resistance at its 200-day MA of $1.49.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

Shares of Ventas Rise Above Previous 52-...

Ventas (NYSE:VTR) traded today at a new 52-week high of $70.11. So far today approxima ...

Shares of Validus Holdings Rise to a New...

Shares of Validus Holdings (NYSE:VR) traded at a new 52-week high today of $41.42. So ...

Watch for Continued Gains in Shares of V...

Shares of VF Corp (NYSE:VFC) traded today at $74.38, breaking its 52-week high. This n ...

Shares of Valspar Have Risen Above Previ...

Valspar (NYSE:VAL) traded at a new 52-week high today of $87.59. Approximately 849,000 ...

Visa: The Winning Streak Continues (V)...

Visa (NYSE:V) traded today at a new 52-week high of $258.00. So far today approximatel ...

Union Pacific Looks to Continue to Trade...

Union Pacific (NYSE:UNP) traded today at a new 52-week high of $123.61. This new high ...

Shares of Textron Have Risen Above Previ...

Textron (NYSE:TXT) traded at a new 52-week high today of $44.47. This new high was rea ...

Shares of Take-Two Interactive Software ...

Take-Two Interactive Software (NASDAQ:TTWO) traded today at a new 52-week high of $28.0 ...